PL2690088T3 - Mieszana krystaliczna agomelatyna (postać - viii), sposób wytwarzania i jej zastosowanie oraz kompozycja farmaceutyczna ją zawierająca - Google Patents
Mieszana krystaliczna agomelatyna (postać - viii), sposób wytwarzania i jej zastosowanie oraz kompozycja farmaceutyczna ją zawierającaInfo
- Publication number
- PL2690088T3 PL2690088T3 PL12761142T PL12761142T PL2690088T3 PL 2690088 T3 PL2690088 T3 PL 2690088T3 PL 12761142 T PL12761142 T PL 12761142T PL 12761142 T PL12761142 T PL 12761142T PL 2690088 T3 PL2690088 T3 PL 2690088T3
- Authority
- PL
- Poland
- Prior art keywords
- viii
- preparation
- pharmaceutical composition
- composition containing
- mixed crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100706340A CN102690209A (zh) | 2011-03-23 | 2011-03-23 | 阿戈美拉汀的混晶(形式-ⅷ)、其制备方法、应用和包含其的药物组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2690088T3 true PL2690088T3 (pl) | 2017-09-29 |
Family
ID=46855965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12761142T PL2690088T3 (pl) | 2011-03-23 | 2012-03-22 | Mieszana krystaliczna agomelatyna (postać - viii), sposób wytwarzania i jej zastosowanie oraz kompozycja farmaceutyczna ją zawierająca |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20140088197A1 (pl) |
| EP (1) | EP2690088B1 (pl) |
| JP (1) | JP6203171B2 (pl) |
| KR (1) | KR20130136546A (pl) |
| CN (2) | CN102690209A (pl) |
| AR (1) | AR085915A1 (pl) |
| AU (1) | AU2012231548B2 (pl) |
| BR (1) | BR112013024022A2 (pl) |
| CA (1) | CA2829690C (pl) |
| CY (1) | CY1118751T1 (pl) |
| DK (1) | DK2690088T3 (pl) |
| EA (1) | EA023278B1 (pl) |
| ES (1) | ES2626030T3 (pl) |
| GE (1) | GEP201606567B (pl) |
| HK (1) | HK1193086A1 (pl) |
| HR (1) | HRP20170575T1 (pl) |
| HU (1) | HUE034329T2 (pl) |
| LT (1) | LT2690088T (pl) |
| MA (1) | MA34959B1 (pl) |
| MD (1) | MD4484C1 (pl) |
| ME (1) | ME02731B (pl) |
| MX (1) | MX355551B (pl) |
| MY (1) | MY166444A (pl) |
| PL (1) | PL2690088T3 (pl) |
| PT (1) | PT2690088T (pl) |
| RS (1) | RS55918B1 (pl) |
| SG (1) | SG193305A1 (pl) |
| SI (1) | SI2690088T1 (pl) |
| WO (1) | WO2012126386A1 (pl) |
| ZA (1) | ZA201306761B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12012000132A1 (en) * | 2011-06-09 | 2014-10-20 | Servier Lab | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them |
| MX369303B (es) * | 2013-07-29 | 2019-11-05 | Servier Lab | Nuevos complejos de agomelatina y de acidos sulfonicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
| CN104529804A (zh) * | 2014-12-11 | 2015-04-22 | 连云港金康医药科技有限公司 | 阿戈美拉汀的新晶型 |
| EP3075724B1 (en) | 2015-03-31 | 2023-07-12 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Solid form of agomelatine |
| EP3466923A1 (en) | 2017-10-09 | 2019-04-10 | KRKA, d.d., Novo mesto | Process for the preparation of agomelatine in crystalline form |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US7498466B2 (en) * | 2004-02-13 | 2009-03-03 | Les Laboratoires Servier | Process for the synthesis and crystalline form of agomelatine |
| FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
| FR2889521B1 (fr) * | 2005-08-03 | 2007-12-28 | Servier Lab | Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| FR2889523B1 (fr) * | 2005-08-03 | 2007-12-28 | Servier Lab | Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| FR2889522B1 (fr) * | 2005-08-03 | 2007-12-28 | Servier Lab | Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| FR2923482B1 (fr) * | 2007-11-09 | 2010-01-29 | Servier Lab | Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| CN101585779B (zh) * | 2009-03-10 | 2014-04-02 | 上海医药工业研究院 | 阿戈美拉汀的晶型vi及其制备方法和应用 |
| WO2011006387A1 (zh) * | 2009-07-11 | 2011-01-20 | 浙江华海药业股份有限公司 | 阿戈美拉汀的制备方法、阿戈美拉汀晶形及其制备方法 |
| CN101723844A (zh) * | 2009-11-21 | 2010-06-09 | 浙江华海药业股份有限公司 | 一种阿戈美拉汀晶形b、它的制备方法和包含它的药物组合物 |
| CN101955440B (zh) * | 2009-07-17 | 2014-04-09 | 江苏万特制药有限公司 | 一种阿戈美拉汀新晶型及其制备方法 |
| EP2319827A1 (en) * | 2009-11-09 | 2011-05-11 | Ratiopharm GmbH | Process for the production of polymorph form I of agomelatine |
| CN101781226B (zh) * | 2009-12-23 | 2012-03-28 | 天津泰普药品科技发展有限公司 | 阿戈美拉汀及其药物组合物 |
| CN101792400B (zh) * | 2010-03-16 | 2013-01-30 | 华东师范大学 | 一种阿戈美拉汀的合成方法 |
| EP2580183B1 (en) * | 2010-06-10 | 2014-07-23 | Gador S.A. | New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide |
| WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
| CN102452952A (zh) * | 2010-11-03 | 2012-05-16 | 天津药物研究院 | 一种高纯度的i型阿戈美拉汀晶体制备方法 |
-
2011
- 2011-03-23 CN CN2011100706340A patent/CN102690209A/zh active Pending
-
2012
- 2012-03-22 MX MX2013010634A patent/MX355551B/es active IP Right Grant
- 2012-03-22 EP EP12761142.4A patent/EP2690088B1/en active Active
- 2012-03-22 WO PCT/CN2012/072818 patent/WO2012126386A1/zh active Application Filing
- 2012-03-22 PL PL12761142T patent/PL2690088T3/pl unknown
- 2012-03-22 MD MDA20130074A patent/MD4484C1/ro not_active IP Right Cessation
- 2012-03-22 SI SI201230949A patent/SI2690088T1/sl unknown
- 2012-03-22 ES ES12761142.4T patent/ES2626030T3/es active Active
- 2012-03-22 CN CN201280013429.3A patent/CN103476743B/zh active Active
- 2012-03-22 BR BR112013024022A patent/BR112013024022A2/pt not_active Application Discontinuation
- 2012-03-22 AU AU2012231548A patent/AU2012231548B2/en not_active Ceased
- 2012-03-22 MA MA36226A patent/MA34959B1/fr unknown
- 2012-03-22 LT LTEP12761142.4T patent/LT2690088T/lt unknown
- 2012-03-22 RS RS20170307A patent/RS55918B1/sr unknown
- 2012-03-22 GE GEAP201213264A patent/GEP201606567B/en unknown
- 2012-03-22 SG SG2013066600A patent/SG193305A1/en unknown
- 2012-03-22 JP JP2014500244A patent/JP6203171B2/ja not_active Expired - Fee Related
- 2012-03-22 EA EA201301065A patent/EA023278B1/ru not_active IP Right Cessation
- 2012-03-22 HU HUE12761142A patent/HUE034329T2/en unknown
- 2012-03-22 PT PT127611424T patent/PT2690088T/pt unknown
- 2012-03-22 KR KR1020137027641A patent/KR20130136546A/ko not_active Application Discontinuation
- 2012-03-22 DK DK12761142.4T patent/DK2690088T3/en active
- 2012-03-22 US US14/006,484 patent/US20140088197A1/en not_active Abandoned
- 2012-03-22 MY MYPI2013701574A patent/MY166444A/en unknown
- 2012-03-22 CA CA2829690A patent/CA2829690C/en not_active Expired - Fee Related
- 2012-03-23 AR ARP120100969A patent/AR085915A1/es unknown
-
2013
- 2013-09-09 ZA ZA2013/06761A patent/ZA201306761B/en unknown
-
2014
- 2014-06-24 HK HK14106352.3A patent/HK1193086A1/xx not_active IP Right Cessation
-
2017
- 2017-03-20 CY CY20171100351T patent/CY1118751T1/el unknown
- 2017-04-11 HR HRP20170575TT patent/HRP20170575T1/hr unknown
- 2017-06-12 ME MEP-2017-109A patent/ME02731B/me unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201400769PA (en) | Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof | |
| ME02726B (me) | Amidi oksalne kiseline kao inhibitori neprilizina, njihova farmaceutska kompozicija i njihova priprema | |
| ME02731B (me) | Mješoviti kristalni oblik agomelatina. (oblik-viii), postupak pripreme i njegove primjene i farmaceutski pripravak koji ga sadrži | |
| IL230463A (en) | Benzamides, their preparation and their pharmaceutical preparations | |
| EP2573070A4 (en) | CRYSTAL FORM OF (S) -4-HYDROXY-2-OXO-1-PYRROLIDINACETAMIDE, METHOD OF MANUFACTURE AND USE THEREOF | |
| HRP20181704T1 (hr) | Kristalni oblik kidamida, metoda pripreme i uporabe istog | |
| EP2786982A4 (en) | AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| HK1193087A1 (en) | New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same vii | |
| EP2924042A4 (en) | BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| IL230835B (en) | N-(benzoimidazole)-2-yl)-cyclopropane carboxamides, their preparation and pharmaceutical preparations containing them | |
| EP2781512A4 (en) | OXADIAZOLE COMPOUND AND PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| ZA201209674B (en) | Pharmaceutical compositions comprising paracetamol and process for preparing the same | |
| EP2701689A4 (en) | PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF | |
| EP2743252A4 (en) | TETRAVALENT PLATINUM COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | |
| EP2565180A4 (en) | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| IL234614B (en) | Pharmaceutical composition and preparation method thereof | |
| PL2736496T3 (pl) | Kompozycja farmaceutyczna zawierająca środek przeciwmuskarynowy i sposób jej wytwarzania | |
| HU1000591D0 (en) | Stabilized pharmaceutical compositions containing capsaicin and process for their preparation | |
| ZA201105460B (en) | Pharmaceutical composition comprising an isoxazole antireumatic agent and method for the preparation thereof | |
| GEP20156304B (en) | Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof |